Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis
Pierfrancesco Visaggi, Brigida Barberio, Giulio Del Corso, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2019-2030
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 6, pp. 951-963
Closed Access | Times Cited: 17
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry
Emilio J. Laserna‐Mendieta, Pilar Navarro, Sergio Casabona, et al.
United European Gastroenterology Journal (2024) Vol. 12, Iss. 5, pp. 585-595
Open Access | Times Cited: 14
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target
Alexander C. Ford, Heidi M. Staudacher, Nicholas J. Talley
Gut (2024) Vol. 73, Iss. 7, pp. 1199-1211
Closed Access | Times Cited: 14
Outcomes in eosinophilic esophagitis: current understanding and future directions
Sara Urbani, Giulio Dinardo, Maria Cristina Artesani, et al.
Current Opinion in Allergy and Clinical Immunology (2025)
Closed Access | Times Cited: 1
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7
Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
Pierfrancesco Visaggi, I. Solinas, Federica Baiano Svizzero, et al.
Diagnostics (2023) Vol. 13, Iss. 17, pp. 2806-2806
Open Access | Times Cited: 13
Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice
Xu Zuo, Yinuo Gu, Xiaoping Guo, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 673-688
Open Access | Times Cited: 4
Crafting a Therapeutic Pyramid for Eosinophilic Esophagitis in the Age of Biologics
Salvatore Oliva, Seema S. Aceves, Noam Zevit, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 9, pp. 1763-1769
Open Access | Times Cited: 4
Determinant factors for first-line treatment choice and effectiveness in pediatric eosinophilic esophagitis: an analysis of the EUREOS EoE CONNECT registry
Pilar Navarro, Sara Feo‐Ortega, Sergio Casabona, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 8, pp. 3567-3578
Open Access | Times Cited: 4
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024
Pierfrancesco Visaggi, Luisa Bertin, Andrea Pasta, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 15, pp. 2077-2088
Closed Access | Times Cited: 4
The Esophageal Mucosa
Pierfrancesco Visaggi, Evan S. Dellon
Gastrointestinal Endoscopy Clinics of North America (2025)
Closed Access
The Dynamic Evolution of Eosinophilic Esophagitis
Amir Farah, Tarek Assaf, Jawad Hindy, et al.
Diagnostics (2025) Vol. 15, Iss. 3, pp. 240-240
Open Access
Artificial Intelligence Tools for the Diagnosis of Eosinophilic Esophagitis in Adults Reporting Dysphagia: Development, External Validation, and Software Creation for Point-of-Care Use
Pierfrancesco Visaggi, Giulio Del Corso, Federica Baiano Svizzero, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 12, Iss. 4, pp. 1008-1016.e1
Closed Access | Times Cited: 9
Pharmacologic Management of Eosinophilic Esophagitis
Gary W. Falk, Robbie Pesek
Immunology and Allergy Clinics of North America (2024) Vol. 44, Iss. 2, pp. 245-264
Closed Access | Times Cited: 3
Clinical practices and adherence to guidelines for eosinophilic esophagitis: A European survey
Andrea Sorge, Marina Coletta, Luca Elli, et al.
Digestive and Liver Disease (2024)
Closed Access | Times Cited: 3
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes
Pierfrancesco Visaggi, Matteo Ghisa, Edoardo Vespa, et al.
ImmunoTargets and Therapy (2024) Vol. Volume 13, pp. 367-383
Open Access | Times Cited: 3
Author's reply: “The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis and the missing link: Helicobacter pylori infection”
Nicola de Bortoli, Pierfrancesco Visaggi, Edoardo Savarino
Digestive and Liver Disease (2024) Vol. 56, Iss. 11, pp. 1948-1949
Closed Access | Times Cited: 2
Histological Outcomes of Pharmacological Interventions in Eosinophilic Esophagitis for Adults and Children
Muhammad Aziz, Hossein Haghbin, Manesh Kumar Gangwani, et al.
Journal of Clinical Gastroenterology (2024)
Closed Access | Times Cited: 1
Pharmacologic treatment of eosinophilic esophagitis: efficacious, likely efficacious, and failed drugs
Alain Schoepfer, Ekaterina Safroneeva
Inflammatory Intestinal Diseases (2024)
Open Access | Times Cited: 1
Clinical Characteristics, Endoscopic Findings, and Treatment Outcomes in Lymphocytic Esophagitis Compared With Eosinophilic Esophagitis
Pierfrancesco Visaggi, Edoardo Savarino, Giulio Del Corso, et al.
The American Journal of Gastroenterology (2024) Vol. 120, Iss. 2, pp. 469-472
Closed Access | Times Cited: 1
From Pathogenesis to Treatment: Targeting Type-2 Inflammation in Eosinophilic Esophagitis
Alberto Barchi, Francesco Vito Mandarino, Mona‐Rita Yacoub, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1080-1080
Open Access | Times Cited: 1
Biologics for eosinophilic oesophagitis: a systematic review and meta-analysis
Beibei Zeng, Dao‐Yong Jia, Shengen Li, et al.
Annals of Medicine (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Eosinophilic oesophagitis in adults: from symptoms to therapeutic options
Carlo Maria Rossi, Marco Vincenzo Lenti, Giovanni Santacroce, et al.
Internal and Emergency Medicine (2024)
Closed Access | Times Cited: 1
Comparing the relative efficacy of therapeutics for eosinophilic oesophagitis: is counting eosinophils the right target?
Ikuo Hirano, David A. Katzka
Gut (2023) Vol. 72, Iss. 11, pp. 2007-2008
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top